TABLE 1.
Sociodemographic and Health-Related Characteristics of Medicare Part D Beneficiaries Who Received a CMR or Non-CMR Intervention
| Characteristic | 2012 | 2013 | ||||
|---|---|---|---|---|---|---|
| CMR Group (n = 42,253) | Non-CMR (n = 384,477) | P Valuea | CMR Group (n = 38,967) | Non-CMR (n = 342,701) | P Valuea | |
| n (%) | n (%) | n (%) | n (%) | |||
| Gender | ||||||
| Female | 26,740 (63) | 232,222 (60) | < 0.001 | 22,895 (59) | 201,750 (59) | 0.65 |
| Male | 15,513 (37) | 152,255 (40) | 16,072 (41) | 140,936 (41) | ||
| Chronic diseaseb | ||||||
| Hypertension | 38,405 (91) | 357,466 (93) | 35,321 (91) | 316,367 (92) | ||
| Dyslipidemia | 30,854 (73) | 289,591 (75) | 28,605 (73) | 247,457 (72) | ||
| Diabetes | 24,426 (58) | 204,681 (53) | 20,396 (52) | 153,895 (45) | ||
| Depression | 13,676 (32) | 135,709 (35) | 10,560 (27) | 105,131 (31) | ||
| Heart failure | 9,237 (22) | 93,929 (24) | 8,318 (21) | 78,692 (23) | ||
| Respiratory | 10,880 (26) | 90,017 (23) | 8,941 (23) | 79,135 (23) | ||
| Osteoporosis | 6,025 (14) | 53,362 (14) | 3,950 (10) | 37,075 (11) | ||
| Dollars spent on prescription medications (U.S. dollars) | ||||||
| Mean (SD) | 1,912 (2,511) | 1,871 (2,423) | 0.001 | 2,192 (4,011) | 2,071 (3,250) | < 0.001 |
| Median (IQR) | 1,315 (1,101) | 1,291 (1,075) | 1,391 (1,277) | 1,350 (1,214) | ||
| Number of chronic medications | ||||||
| Mean (SD) | 10.7 (3.5) | 10.8 (3.6) | < 0.001 | 11.3 (4.7) | 11.2 (4.8) | 0.05 |
| Median (IQR) | 10 (4) | 10 (5) | 10 (5) | 10 (5) | ||
aAnalysis of the baseline characteristic compared the CMR group with the non-CMR group for each year.
bThese are not mutually exclusive disease categories. Patients with multiple chronic diseases may be represented in 2 or more of these chronic disease categories.
CMR = comprehensive medication review; IQR = interquartile range; non-CMR = noncomprehensive medication review; SD = standard deviation.